(Q34186827)

31 July 2017

0 references

Proton pump inhibitors and risk of fractures: a meta-analysis of 11 international studies (English)

1 reference

31 July 2017

0 references

1 reference

Elaine W Yu

1

1 reference

31 July 2017

Scott R Bauer

series ordinal

2

1 reference

31 July 2017

Paul A Bain

series ordinal

3

1 reference

31 July 2017

Douglas C Bauer

series ordinal

4

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 June 2011

1 reference

American Journal of Medicine

31 July 2017

published in

1 reference

31 July 2017

volume

124

1 reference

31 July 2017

issue

6

1 reference

31 July 2017

page(s)

519-526

1 reference

Use of proton pump inhibitors increased the risk of hip fracture: a population-based case-control study

31 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101476

Use of proton pump inhibitors and risk of hip/femur fracture: a population-based case-control study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101476

Do proton pump inhibitors decrease calcium absorption?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101476

Inhibiting gastric acid production does not affect intestinal calcium absorption in young, healthy individuals: a randomized, crossover, controlled clinical trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101476

Proton pump inhibitors and risk for recurrent Clostridium difficile infection

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101476

Proton pump inhibitor use, hip fracture, and change in bone mineral density in postmenopausal women: results from the Women's Health Initiative

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101476

Proton pump inhibitors and histamine-2 receptor antagonists are associated with hip fractures among at-risk patients

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101476

Long-term safety concerns with proton pump inhibitors

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101476

Acid-suppressive medication use and the risk for hospital-acquired pneumonia

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101476

Acid-suppressive medications and risk of bone loss and fracture in older adults

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101476

Proton-pump inhibitor use and the risk for community-acquired pneumonia

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101476

Use of proton pump inhibitors and risk of osteoporosis-related fractures

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101476

Overuse and inappropriate prescribing of proton pump inhibitors in patients with Clostridium difficile-associated disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101476

Long-term proton pump inhibitor therapy and risk of hip fracture

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101476

Acid suppressive therapy use on an inpatient internal medicine service

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101476

Long-term use of acid suppression started inappropriately during hospitalization

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101476

Homocysteine as a predictive factor for hip fracture in older persons

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101476

A case-control study on adverse effects: H2 blocker or proton pump inhibitor use and risk of vitamin B12 deficiency in older adults

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101476

Measuring inconsistency in meta-analyses

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101476

Advanced methods in meta-analysis: multivariate approach and meta-regression.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101476

Review article: potential gastrointestinal effects of long-term acid suppression with proton pump inhibitors

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101476

Risk factors for hip fracture in men. Hip Fracture Study Group

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101476

Effect of omeprazole, an inhibitor of H+,K(+)-ATPase, on bone resorption in humans

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101476

Calcium absorption and achlorhydria.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101476

Meta-analysis in clinical trials

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101476

Fracture risk in patients receiving acid-suppressant medication alone and in combination with bisphosphonates

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101476

Proton pump inhibitor omeprazole use is associated with low bone mineral density in maintenance haemodialysis patients

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101476

Increase in vertebral fracture risk in postmenopausal women using omeprazole

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101476

Do acid-lowering agents affect vitamin B12 status in older adults?

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101476

Effects of proton pump inhibitors on calcium carbonate absorption in women: a randomized crossover trial

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101476

Short-term omeprazole treatment does not influence biochemical parameters of bone turnover in children.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101476

Proton-Pump Inhibitor Use Is Not Associated With Osteoporosis or Accelerated Bone Mineral Density Loss

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101476

Proton Pump Inhibitor Use and Risk of Hip Fractures in Patients without Major Risk Factors

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101476

Omeprazole, a specific inhibitor of H+-K+-ATPase, inhibits bone resorption in vitro

28 October 2018

1 reference

12 December 2020

Proton pump inhibitors, histamine H2 receptor antagonists, and other antacid medications and the risk of fracture

1 reference

12 December 2020

Proton-pump inhibitors and hypomagnesemic hypoparathyroidism

1 reference

12 December 2020

Associations between homocysteine, bone turnover, BMD, mortality, and fracture risk in elderly women

1 reference

12 December 2020

Long-term gastroesophageal reflux disease therapy improves reflux symptoms in elderly patients: five-year prospective study in community medicine

1 reference

12 December 2020

Proton pump inhibitors linked to fracture risk

1 reference

12 December 2020

Could magnesium depletion play a role on fracture risk in PPI users?

1 reference

12 December 2020

Ingestion of guar-gum hydrolysate partially restores calcium absorption in the large intestine lowered by suppression of gastric acid secretion in rats

1 reference

12 December 2020

10.1016/J.AMJMED.2011.01.007

Identifiers

DOI

1 reference

31 July 2017

1 reference

31 July 2017

1 reference